FDA

The Rise of the Opioids: How Purdue Invented New Markets for OxyContin

Purdue's strategy was to market its opioids directly to patients via brochures, videos, advertisements, and the internet. It also provided information to doctors and...

Purdue Circumvented the Regulator to Promote OxyContin, Hiding Its Real Risk of Addiction

In 2001, the Food and Drug Administration required Purdue to change OxyContin’s patient package inserts to make addiction risks more evident. The company altered...

OxyContin's Academic Marketing: The Studies That Fueled the Opioid Crisis

Purdue Pharmaceuticals used to cite three major studies to argue that in prescribing OxyContin, addiction-risk was not significant. The most influential of those studies...

LATEST NEWS

Is there a “California Effect” in Data Privacy Law? Why the EU is Not the World’s Privacy Cop

It is common lore in data privacy law and other fields that stringent regulatory standards (such as the ones introduced in the...

Governments Were Forced to Restrict Civil Liberties to Deal With Covid-19. More Flexible Constitutions Could Prevent That from Becoming the New Normal

A new paper argues that exploitation of gaps within democratic constitutions during emergencies, such as the Covid-19 pandemic, has the potential to...

The Social Responsibility of Business Includes Profits

Profits these days are often seen as a dirty word, but it is wrong to demonize profits. A company’s responsibility is not...

Academic Gatekeepers, Real and Imagined, Are Threatening the Credibility of the Field of Political Finance 


One objective of political finance is to hold power to account. However, gatekeeping, both direct and indirect, is keeping important work from...

A Call for Comments: Have You Been Affected by Academic Gatekeeping?

On Friday, ProMarket published a piece by Renée Adams about the impact of academic gatekeeping in the political finance. Do you have...